3 news items
Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis
ZLAB
22 May 24
disease. However, current treatment options provide limited efficacy or have safety concerns with long-term use
Zai Lab To Present Final Overall Survival DataFfrom Phase 3 NORA Study of ZEJULA In Platinum-Sensitive Recurrent Ovarian Cancer
ZLAB
6 Mar 24
in this disease setting, regardless of BRCA-gene mutation status. No new safety signals were identified during the long-term follow up period subsequent
Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC)
ZLAB
6 Mar 24
a favorable OS trend versus placebo in this disease setting, regardless of BRCA-gene mutation status. No new safety signals were identified during the long
- Prev
- 1
- Next